This inventor holds 1 USPTO granted patent. Top assignee: Motac Neuroscience Limited. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: Alan Crossman - Innovator in Dyskinesia Treatment
Introduction
Alan Crossman is a notable inventor based in Manchester, GB. He has made significant contributions to the field of neuroscience, particularly in the treatment of dyskinesia. His innovative approach focuses on enhancing H-histamine receptor activity to provide therapeutic benefits.
Latest Patents
Alan Crossman holds a patent related to the treatment of dyskinesia. The patent describes the use of compounds that enhance H-histamine receptor activity, specifically H-histamine receptor agonists, for treating dyskinesia associated with parkinsonian therapy. This invention represents a promising advancement in addressing the challenges faced by patients undergoing such therapies.
Career Highlights
Crossman is affiliated with Motac Neuroscience Limited, where he applies his expertise in developing novel treatments. His work has garnered attention for its potential to improve the quality of life for individuals suffering from dyskinesia.
Collaborations
Throughout his career, Alan has collaborated with esteemed colleagues, including Michael Peter Hill and Jonathan Brotchie. These partnerships have contributed to the advancement of research and development in the field of neuroscience.
Conclusion
Alan Crossman is a pioneering inventor whose work in dyskinesia treatment showcases the importance of innovation in healthcare. His contributions continue to inspire advancements in therapeutic approaches for neurological disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile